在PCSK9,动脉样硬化和糖尿病的背景下Rap1
Heena Agarwal1, Brea Tinsley1, Amesh K Sarecha1
1Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Current atherosclerosis reports
|November 18, 2023
概括
拉斯相关蛋白1 (Rap1) 在调节PCSK9和动脉样硬化方面发挥着关键作用. 针对Rap1可能为2型糖尿病和心脏代谢疾病提供治疗效益.
科学领域:
- 心血管科学 心血管科学
- 代谢性疾病研究研究
- 分子生物学分子生物学
背景情况:
- 心脏代谢性疾病,包括肥胖,葡萄糖不耐受,脂质不良和动脉样硬化,是导致死亡的主要原因.
- 小型GTPase,Ras相关蛋白1 (Rap1),与心脏代谢功能障碍有关.
研究的目的:
- 突出Rap1在调节PCSK9中的关键作用及其参与动脉样硬化和2型糖尿病.
- 探索针对这些疾病的Rap1的治疗潜力.
主要方法:
- 对现有的文献和来自肥胖和胰岛素抵抗的小鼠模型的证据的审查.
主要成果:
- 在小鼠模型中,Rap1缺乏导致PCSK9和LDL胆固醇增加,加剧动脉样硬化并促进高血糖症.
- Rap1影响血管壁细胞,有助于动脉样硬化进展.
- 肝脏Rap1激活显示出预防2型糖尿病,高胆固醇血清症和动脉样硬化等心脏代谢问题的潜力.
结论:
- Rap1是心脏代谢健康的关键调节者,影响PCSK9水平,脂质概况和葡萄糖代谢.
- 调节Rap1活性,特别是在肝脏中,是预防和管理心脏代谢疾病的有希望的治疗策略.
相关概念视频
Coronary Artery Disease I: Introduction
15
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
15
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
10
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
10


